Ehlers–Danlos syndrome is a group of inherited connective tissue disorders caused by a defect in the synthesis of collagen. Severity of the disease depends on the mutation inherited. The disorder occurs in approximately one in 5,000 births.
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Malfait F, Wenstrup RJ, Paepe AD. Clinical and genetic aspects of Ehlers–Danlos syndrome, classic type. Genet Med. 2010;12:597–605.PubMedCrossRefGoogle Scholar
Solomon JA, Abrams L, Lichtenstein GR. GI manifestations of Ehlers–Danlos syndrome. Am J Gastroenterol. 1996;91:2282–8.PubMedGoogle Scholar
Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers–Danlos syndrome type IV, the vascular type. N Eng J Med. 2000;342:673–80.CrossRefGoogle Scholar
Bläker H, Funke B, Hausser I, et al. Pathology of the large intestine in patients with vascular type Ehlers-Danlos syndrome. Virchows Arch. 2007;450:713–7.PubMedCrossRefGoogle Scholar
Smith LT, Schwarze U, Goldstein J, Byers PH. Mutations in the COL3A1 gene results in Ehlers–Danlos syndrome type IV and alterations in the size and distribution of the major collage fibrils of the dermis. J Invest Dermatol. 1997;108:241–7.PubMedCrossRefGoogle Scholar
Ward SK, Roenigk HH, Gordon KB. Dermatological manifestations of gastroenterological disorders. Gastroenterol Clin North Am. 1998;27:624–5.CrossRefGoogle Scholar